Related Experiment Video
Updated: Oct 11, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Ligand-independent dimerization and activation of the oncogenic Xmrk receptor by two mutations in the extracellular
A Gómez1, C Wellbrock, H Gutbrod
1Physiological Chemistry I, Biocenter (Theodor Boveri Institute), University of Würzburg, Am Hubland, 97074 Würzburg, Germany.
Abstract:
Overexpression of the oncogenic receptor tyrosine kinase ONC-Xmrk is the first step in the development of hereditary malignant melanoma in the fish Xiphophorus. However, overexpression of its proto-oncogene counterpart (INV-Xmrk) is not sufficient for the oncogenic function of the receptor. Compared with INV-Xmrk, the ONC-Xmrk receptor displays 14 amino acid changes, suggesting the presence of activating mutations. To identify such activating mutations, a series of chimeric and mutant receptors were studied. None of the mutations present in the intracellular domain was found to be involved in receptor activation. In the extracellular domain, we found two mutations responsible for activation of the receptor. One is the substitution of a conserved cysteine (C578S) involved in intramolecular disulfide bonding. The other is a glycine to arginine exchange (G359R) in subdomain III. Either mutation leads to constitutive dimer formation and thereby to activation of the ONC-Xmrk receptor. Besides, the presence of these mutations slows down the processing of the Xmrk receptor in the endoplasmic reticulum, which is apparent as an incomplete glycosylation.
Insights
Activating mutations in the extracellular domain of the oncogenic receptor tyrosine kinase ONC-Xmrk drive melanoma development in Xiphophorus fish. These mutations cause constitutive dimer formation and altered receptor processing.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hereditary malignant melanoma in Xiphophorus fish originates from the overexpression of the oncogenic receptor tyrosine kinase ONC-Xmrk.
- Proto-oncogene INV-Xmrk overexpression alone does not confer oncogenic function, indicating specific activating mutations in ONC-Xmrk are crucial.
Purpose of the Study:
- To identify the specific activating mutations responsible for the oncogenic function of the ONC-Xmrk receptor.
- To elucidate the mechanism by which these mutations lead to receptor activation and influence its processing.
Main Methods:
- Construction and analysis of chimeric and mutant ONC-Xmrk receptors.
- Investigation of mutations within both the intracellular and extracellular domains of the receptor.
- Assessment of receptor dimerization, activation status, and endoplasmic reticulum processing, including glycosylation.
Main Results:
- Mutations in the intracellular domain of ONC-Xmrk were not found to be responsible for receptor activation.
- Two specific mutations in the extracellular domain were identified as critical for ONC-Xmrk activation: C578S (cysteine substitution) and G359R (glycine to arginine exchange in subdomain III).
- Both identified mutations induce constitutive dimer formation, leading to receptor activation, and also impair receptor processing and glycosylation in the endoplasmic reticulum.
Conclusions:
- The oncogenic function of ONC-Xmrk in Xiphophorus melanoma is driven by specific activating mutations in its extracellular domain.
- These mutations promote constitutive dimerization and activation of the receptor tyrosine kinase, contributing to tumor development.
- The identified mutations also impact receptor maturation, suggesting a link between altered processing and oncogenesis.
Related Concept Videos
Receptor Tyrosine Kinases
MAPK Signaling Cascades
Mitogens and the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Enzyme-linked Receptors

